Fisher Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.14B | Buy |
10,845,708
+44,991
| +0.4% | +$8.68M | 0.73% | 39 |
|
|
2025
Q4 | $1.99B | Buy |
10,800,717
+219,355
| +2% | +$38.5M | 0.68% | 39 |
|
|
2025
Q3 | $1.62B | Buy |
10,581,362
+233,372
| +2% | +$35.3M | 0.59% | 48 |
|
|
2025
Q2 | $1.45B | Buy |
10,347,990
+265,260
| +3% | +$37.2M | 0.57% | 54 |
|
|
2025
Q1 | $1.48B | Buy |
10,082,730
+4,602,804
| +84% | +$666M | 0.64% | 50 |
|
|
2024
Q4 | $718M | Buy |
5,479,926
+239,846
| +5% | +$33.6M | 0.29% | 79 |
|
|
2024
Q3 | $817M | Buy |
5,240,080
+262,087
| +5% | +$42.3M | 0.33% | 76 |
|
|
2024
Q2 | $776M | Buy |
4,977,993
+151,287
| +3% | +$22.8M | 0.34% | 77 |
|
|
2024
Q1 | $654M | Buy |
4,826,706
+138,609
| +3% | +$18.4M | 0.31% | 87 |
|
|
2023
Q4 | $631M | Buy |
4,688,097
+102,593
| +2% | +$13.3M | 0.33% | 80 |
|
|
2023
Q3 | $621M | Buy |
4,585,504
+119,908
| +3% | +$16.4M | 0.35% | 87 |
|
|
2023
Q2 | $639M | Buy |
4,465,596
+90,563
| +2% | +$13.3M | 0.35% | 85 |
|
|
2023
Q1 | $607M | Buy |
4,375,033
+23,822
| +0.5% | +$3.21M | 0.37% | 88 |
|
|
2022
Q4 | $590M | Sell |
4,351,211
-120,250
| -3% | -$15.1M | 0.4% | 78 |
|
|
2022
Q3 | $490M | Sell |
4,471,461
-6,222,405
| -58% | -$789M | 0.37% | 80 |
|
|
2022
Q2 | $1.41B | Buy |
10,693,866
+272,443
| +3% | +$35.7M | 1% | 25 |
|
|
2022
Q1 | $1.38B | Buy |
10,421,423
+366,480
| +4% | +$43.9M | 0.82% | 31 |
|
|
2021
Q4 | $1.17B | Buy |
10,054,943
+260,129
| +3% | +$30.6M | 0.66% | 42 |
|
|
2021
Q3 | $1.18B | Buy |
9,794,814
+379,567
| +4% | +$44.2M | 0.73% | 35 |
|
|
2021
Q2 | $1.13B | Buy |
9,415,247
+220,903
| +2% | +$24.2M | 0.71% | 36 |
|
|
2021
Q1 | $914M | Buy |
9,194,344
+268,957
| +3% | +$27M | 0.64% | 45 |
|
|
2020
Q4 | $892M | Buy |
8,925,387
+254,047
| +3% | +$26.9M | 0.67% | 41 |
|
|
2020
Q3 | $950M | Buy |
8,671,340
+207,867
| +2% | +$23.1M | 0.83% | 28 |
|
|
2020
Q2 | $895M | Buy |
8,463,473
+185,186
| +2% | +$19.1M | 0.87% | 30 |
|
|
2020
Q1 | $739M | Buy |
8,278,287
+92,933
| +1% | +$8.75M | 0.92% | 32 |
|
|
2019
Q4 | $816M | Buy |
8,185,354
+54,373
| +0.7% | +$5.12M | 0.82% | 37 |
|
|
2019
Q3 | $725M | Buy |
8,130,981
+178,835
| +2% | +$15.5M | 0.8% | 36 |
|
|
2019
Q2 | $657M | Buy |
7,952,146
+264,847
| +3% | +$20.8M | 0.73% | 41 |
|
|
2019
Q1 | $622M | Buy |
7,687,299
+204,679
| +3% | +$16.1M | 0.73% | 42 |
|
|
2018
Q4 | $568M | Buy |
7,482,620
+724,258
| +11% | +$56.6M | 0.78% | 38 |
|
|
2018
Q3 | $535M | Buy |
6,758,362
+218,391
| +3% | +$16.5M | 0.65% | 46 |
|
|
2018
Q2 | $459M | Buy |
6,539,971
+267,891
| +4% | +$19.3M | 0.6% | 55 |
|
|
2018
Q1 | $439M | Buy |
6,272,080
+313,414
| +5% | +$21.7M | 0.58% | 53 |
|
|
2017
Q4 | $414M | Buy |
5,958,666
+157,879
| +3% | +$10.6M | 0.54% | 60 |
|
|
2017
Q3 | $393M | Buy |
5,800,787
+259,859
| +5% | +$16.4M | 0.55% | 62 |
|
|
2017
Q2 | $378M | Buy |
5,540,928
+4,580,382
| +477% | +$299M | 0.57% | 61 |
|
|
2017
Q1 | $59.8M | Sell |
960,546
-14,954
| -2% | -$871K | 0.1% | 154 |
|
|
2016
Q4 | $53.3M | Sell |
975,500
-13,293
| -1% | -$755K | 0.09% | 161 |
|
|
2016
Q3 | $65M | Buy |
988,793
+819,303
| +483% | +$53.6M | 0.12% | 133 |
|
|
2016
Q2 | $10.2M | Buy |
169,490
+52,785
| +45% | +$3.07M | 0.02% | 292 |
|
|
2016
Q1 | $6.93M | Buy |
116,705
+5,902
| +5% | +$355K | 0.01% | 319 |
|
|
2015
Q4 | $7.52M | Buy |
110,803
+96,829
| +693% | +$6.35M | 0.01% | 321 |
|
|
2015
Q3 | $889K | Buy |
+13,974
| New | +$919K | ﹤0.01% | 507 |
|
Other funds holding AZN
IA
VCM
VAM